Puma Biotechnology Initiates ALISCA-Breast1 Phase II Trial Of Alisertib In Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer
Puma Biotechnology Initiates ALISCA-Breast1 Phase II Trial Of Alisertib In Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer
puma biotechnology啓動ALISCA-Breast1 II期臨床試驗,以阿利瑟替治療雌激素受體陽性、HER2陰性轉移性乳腺癌
Puma Biotechnology Initiates ALISCA-Breast1 Phase II Trial Of Alisertib In Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer
Puma Biotechnology 啓動 Alisertib 治療激素受體陽性、HER2 陰性的轉移性乳腺癌的 Alisca-Breast1 II 期試驗